Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs IBB✓SelectedUSD · IBBGSK vs IBB performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs IBB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+65.3%
IBB return
+86.1%
Excess return
-20.8%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioIBBExcessAlpha
1D+0.5%-0.4%+1.0%+0.7%
7D+1.1%-0.5%+1.7%+1.4%
30D+6.3%+4.6%+1.8%+3.7%
3M+1.8%+6.8%-5.0%-1.9%
6M+1.7%+23.1%-21.5%-9.0%
YTD+6.5%+26.0%-19.5%-5.9%
1Y+9.5%+30.4%-20.9%-4.9%
3Y+65.3%+85.4%-20.1%+25.1%
All+65.3%+86.1%-20.8%+25.1%

Cumulative growth

Daily Returns

Daily percentage return beside IBB.

Daily Out/Under-Performance

Portfolio return minus IBB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × IBB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded IBB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling